ArticleOncoTargets and therapy2015

Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair.

Kai Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.